Evidence map›Paper›PMID 40781853›Full record

ArticleCancer2025

The American Cancer Society National Lung Cancer Roundtable strategic plan: Changing the lung cancer story: Addressing survivorship, stigma, and nihilism to facilitate transformation.

Jamie L Studts, Lisa Carter-Bawa, Heidi A Hamann, Robert A Smith, Ella A Kazerooni, Lauren S Rosenthal, Stigma and Nihilism Task Group of the American Cancer Society National Lung Cancer Roundtable

Abstract read
In one paragraph

Article in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jamie L StudtsDivision of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.ORCID https://orcid.org/0000-0003-3922-3597
Lisa Carter-BawaCancer Prevention Precision Control Institute, Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID https://orcid.org/0000-0002-6448-6033
Heidi A HamannDepartment of Psychology, University of Arizona, Tucson, Arizona, USA.ORCID https://orcid.org/0000-0002-3207-0949
Robert A SmithCenter for Early Cancer Detection Science, American Cancer Society, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-3344-2238
Ella A KazerooniDepartments of Radiology and Internal Medicine, University of Michigan/Michigan Medicine, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0001-5859-8744
Lauren S RosenthalPatient Support Department, National Lung Cancer Roundtable, American Cancer Society, Atlanta, Georgia, USA.
Stigma and Nihilism Task Group of the American Cancer Society National Lung Cancer Roundtable

Funding

Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural HypothesisR01CA262719 · NCI · UNIVERSITY OF ARIZONA · PI HAMANN, HEIDI ANN, RUIZ, JOHN M · 2021 to 2025
$3.3M
Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and CommunitiesR01CA254734 · NCI · UNIVERSITY OF COLORADO DENVER · PI Jerod L Stapleton, Jamie L Studts · 2021 to 2026
$2.4M
American Cancer Society National Lung Cancer RoundtableNCI NIH HHS R01 CA254734NCI NIH HHS R01CA254734NCI NIH HHS R01CA262719
6 · The paper itself

Abstract

Innovations across the lung cancer continuum, from risk reduction through end-of-life care, have transformed the lung cancer landscape, and are dramatically altering the trajectory of lung cancer outcomes. Although the lung cancer community has been infused with optimism and hope regarding these positive developments, persistent societal perspectives regarding lung cancer and the complex relationship with smoking have been substantially slower to change. These barriers constrain the implementation of innovative and effective care, and hinder progress toward reducing lung cancer incidence and mortality. To address the prevailing societal barriers, the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) launched the Survivorship, Stigma, and Nihilism Task Group (SSNTG) soon after the inaugural 2017 ACS NLCRT meeting. Engaging a diverse group of individuals and organizations with expertise in these cardinal domains, the SSNTG, which consisted of clinicians, advocates, and researchers representing different disciplines and experiences, convened to develop a strategic plan to improve lung cancer survivorship and eliminate lung cancer stigma and nihilism as essential components of achieving optimal lung cancer outcomes. The SSNTG established a trilateral mission and launched the Campaign to End Lung Cancer Stigma and other efforts to support lung cancer survivorship and address lung cancer-related nihilism and fatalism. This commentary highlights the multilayered work of the SSNTG, including (1) background justification for each of the three targeted areas, (2) active initiatives to reduce lung cancer stigma and nihilism and improve lung cancer survivorship, and (3) next steps that the task group plans to pursue to support the ACS NLCRT mission.

Indexed as

Cancer SurvivorsLung NeoplasmsSocial StigmaSurvivorshipAmerican Cancer SocietyHumansUnited Stateslung cancer fatalismlung cancer nihilismlung cancer stigmalung cancer survivorship

Identifiers

PMID40781853
PMCPMC12995422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.